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Effect of dietary protein intake on albumin homeostasis in nepbrotie
patients. Animals with experimental renal disease maintained on diets
restricted in protein develop less severe renal lesions and less protein-
uria than do animals maintained on a normal or high protein diet. To
determine whether restriction of dietary protein will reduce urinary
albumin excretion in patients with established nephroses and whether
such dietary restriction will result in decreased albumin pools, we
performed paired studies on nine nephrotic patients. They were fed
sequential diets with a protein content of 1.6 and then 0.8 glkg body wt,
each for 2 weeks. Caloric intake remained constant at 35 Kcallkg. In six
patients the high protein diet was fed first; in three the order of dietary
administration was reversed. Urinary albumin excretion was reduced
on the low protein diet in all patients regardless of dietary order. Both
the renal clearance of albumin and the fractional renal albumin clear-
ance were reduced significantly on the low protein diet. The rate of
albumin synthesis was greater on the high protein diet, but so was the
rate of albuminuria. Despite the higher rate of albumin synthesis during
the period of high protein intake, serum albumin concentration and
plasma albumin mass were both less than during the period of low
protein intake. Thus, dietary protein restriction in patients with estab-
lished nephrosis results in decreased urinary albumin excretion in
excess of any reduction in creatinine clearance. Total albumin mass is
preserved and plasma albumin mass is actually increased during the
period of dietary protein restriction, Protein restriction may be feasible
in nephrotic patients. The strategy of increasing serum albumin con-
centration in these patients by feeding them a high protein diet may fail
because of the effect of high protein diets on renal albumin excretion.
The nephrotic syndrome is the result of glomerular protein-
uria and is identified by albuminuria, hypoalbuminemia, and
depletion of both the plasma and extravascular albumin poois
[1, 21. High protein diets are recommended for management of
nephrotic patients in the hope that albumin synthesis and serum
albumin concentration will be optimized [3, 4]. It is clear that a
diet composed of a high ratio of calories to protein leads to
reduced albumin synthesis and depletion of body albumin
pools, so the fears of potential protein malnutrition occurring in
nephrotic patients receiving a low protein diet are not un-
founded [5, 6]. Fan [7] however, observed that when nephrotic
children were fed a diet rich in protein, urinary protein excre-
tion increased, but serum protein concentration did not. To our
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knowledge, it is not known what effect, if any, reduction in
dietary protein intake would have on urinary albumin excretion
or on body albumin stores in patients with nephrosis. This is an
issue of concern because it has become apparent that some
renal diseases may be arrested by a low protein diet and
accelerated by a diet rich in protein [8, 9]. Nephrotic rats fed a
high protein diet manifest increased renal albumin clearance,
which results in more severe hypoalbuminemia than rats fed a
low protein diet. However, these studies evaluated the effect of
different dietary intakes on the development of albuminuria,
since the animals were placed in a dietary group prior to the
onset of albuminuria [101. The studies reported herein assess
the effect of changes in dietary protein intake both upon urinary
albumin excretion and albumin metabolism in patients with
established nephrotic syndrome to determine whether dietary
maneuvers produce a change in urinary albumin excretion, and
whether patients suffer depletion of any albumin pool while
consuming a diet with modest protein restriction.
Methods
Patients
Patients with proteinuria greater than 3.5 g124 hr were asked
to participate in this study. Patient 1 was referred by a private
medical practitioner. Patients 2 through 9 were clinic patients at
the Martinez Veterans Administration Medical Center,
Martinez, California, USA, or the San Francisco Veterans
Administration Hospital, San Francisco, California, USA. In-
formed consent was obtained from all patients. The patients
ranged in age from 39 to 77. Patients I through 5 and 7 through
9 were men. Renal biopsy specimens were taken prior to the
study in seven patients. Patients 3, 6, and 7 had membranous
nephropathy; patient 1, focal segmental glomerulosclerosis;
patients 4 and 8, amyloidosis; and patient 5, membranoprolif-
erative glomerulonephritis. A clinical diagnosis of diabetic
nephropathy was made in patient 2. Patient 9 had a solitary
functioning kidney and no biopsy specimen was taken. All
patients had proteinuria for at least 6 months prior to this study.
Informed consent was obtained from each patient. Patients 1
and 2 were admitted to the General Clinical Research Center at
San Francisco General Hospital Medical Center. Patients 3 to 9
were admitted to the Medical Service at the Martinez Veterans
Administration Medical Center. Patients 1 to 6 were placed on
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a fixed metabolic diet containing 1.6 g of protein and 35 Kcallkg
of body wt. After 2 days on this diet, all patients received 10
drops of Lugol's solution 12 hr and one hr before injection of
125j albumin to block thyroid uptake of 125j 125j albumin, 10 Ci
(Mallinkrodt, Inc., St. Louis, Missouri, USA), was injected into
a peripheral vein. Blood samples (3 ml) were obtained at 5, 15,
and 60 mm and 2, 5, and 10 hr. Additional samples were drawn
24 hr after the injection and daily for 2 weeks. Urine specimens
were collected daily. Following this period of high protein
intake, patients were placed on a diet providing 0.8 g of protein
and 35 Kcallkg of body wt with isocaloric replacement of
carboydrate for protein. This diet was maintained for a 5- to
14-day equilibration period. Albumin turnover was then mea-
sured in an identical fashion as during the high protein period.
In patients 7 to 9 the order of diet administration was
reversed. These patients started on the 0.8 glkg protein diet.
Following the 14-day study period, they were fed a 1.6 g/kg
protein diet for a 10-day to 2-week equilibration period follow-
ing which albumin turnover studies were performed for 14 days
as described above.
Measurement of albumin catabolism, synthesis and
distribution
One milliliter of each serum sample was counted in a gamma
counter (Packard 3002) for three 10-mm periods. The average
value was recorded as the counts of 1251 per ml. Urine speci-
mens were treated in a similar fashion. Urine specimens were
then precipitated with 10% trichloroacetic acid (TCA) to deter-
mine the fraction of nonprecipitable 1251. The samples were
centrifuged in a microfuge (Beckman, Palo Alto, California,
USA) for 5 mm. The pellet was dissolved in 1% sodium
hydroxide and reprecipitated. The resulting pellet was dis-
solved in a total volume of 1 ml of 1% sodium hydroxide. The
TCA supematant and the dissolved pellet were each counted
for three 10-mm periods in a gamma counter (Packard 3002).
Urine samples were each determined in triplicate.
Total albumin turnover (synthesis) and albumin catabolism
were each calculated using two independent methods, as we
have described previously [101. Briefly, total loss is measured
by a pharmacokinetic method, integrating the plasma radioac-
tivity curve [11, 12]. The dose of 125J injected divided by the
integral of the plasma radioactivity curve is a clearance term.
The product of this term and the serum albumin concentration
is then total albumin loss—by all routes [13]. Plasma volume is
calculated by isotope dilution and plasma albumin mass (PAM)
is equal to the product of plasma volume and serum albumin
concentration [13]. Steady-state volume of distribution was
measured by the noncompartmental method of Benet and
Galeazzi [111. Total albumin mass (TAM) is the product of the
plasma albumin concentration and the apparent volume of
distribution of albumin. Extravascular albumin mass (EVAM)
is TAM minus PAM. Catabolism is measured, using the
pharmacokinetic method, by subtracting measured albumin
loss, in this case total urine albumin loss, from total albumin
turnover. Using this method, albumin lost by a nonurinary
route would appear as catabolized albumin. The kinetic method
suffers from the necessity of subtracting urinary losses from
total loss to derive albumin catabolic rate, rather than directly
measuring the rate of catabolism.
Albumin turnover measured by this method will equal the
albumin synthesis rate if patients are in steady state, that is, if
serum albumin concentration and urinary albumin excretion
rates remain constant.
An alternative method for measuring albumin catabolic rate
that is useful only in the presence of proteinuria was developed
by Gitlin and Janeway [14]. The urine specimens are collected
until the excretion rate of 125j is negligible. The average specific
radioactivity of urinary albumin is determined and total urinary
nonprotein bound 125j is measured as well. Albumin catabolic
rate is then
Albumin catabolic rate =
Urinary nonprotein 125j (total)
Specific radioactivity of
urinary albumin x (total time)
(1)
This method is based on the observation that the specific
radioactivity of urinary albumin is equal to the specific radio-
activity of serum albumin at any given time, and the iodine
released from catabolism of 1251-labeled albumin all appears in
the urine as TCA soluble 125J In this case, albumin synthesis is
derived as the sum of urinary albumin loss plus albumin
catabolism.
This method of measuring catabolic rate depends on a con-
stant relationship between albuminuria and albumin catabolic
rate throughout the experimental period but is unaffected by
variation in the rate of albuminuria or by delay in iodine
excretion.
The fractional catabolic rate of albumin is defined as the
fraction of the plasma albumin pool catabolized per unit time
and is calculated as the ratio of albumin catabolic rate and
plasma albumin mass times 100 [2, 15].
Albumin was measured both in serum and urine by electroim-
munodiffusion [16]. Total protein was measured by the method
of Bradford [17] using a albumin standard. Creatinine was
measured in serum and urine daily [18].
Creatinine clearance is represented as the mean of 14 values
determined for each patient. Urinary albumin clearance was
calculated using the mean urinary albumin excretion rate and
mean serum albumin concentration. Fractional excretion of
albumin is the renal albumin clearance divided by the creatinine
clearance.
Statistics
Each set of data was tested to determine whether the data
were normally distributed using the Wilk-Shapiro test. Statisti-
cal comparison was by the Student's paired t test for normally
distributed data. When data points were non-normally distrib-
uted, the Wilcoxon Sign Rank Test was used [19]. Results are
expressed as means SEM.
Results
Urinary albumin excretion was less in all patients during the
low protein period by an average of 2.74 0.88 g/l .73 m2/24 hr
(Table 1, Fig. 1B). Urinary albumin excretion did not vary with
time on either the high or low protein diet. The difference in
urinary albumin excretion was evident on the first day after the
5 to 14 days between each study period. Since neither serum
albumin concentration, urinary albumin excretion rate, nor
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Table 1. Parameters of albumin homeostasis in nephrotic patients on high and low protein dietsa
Patient
no. Diet
Weight
kg
Surface
area
m2
Serum
albumin
g/dl
Serum
protein
gIdi
Urinary
albumin loss
g/24 hr/i .73 ,n
Urinary protein
loss
g/24 hr/i .73 m2
Creatinine
clearance
cc/mm
1.73 m2
I HP
LP
102 2.35 .83
.81
3.55
3.25
16.9
9.5
25.0
14.8
48.1
41.6
2 HP
LP
112 2.29 2.60
2.87
4.45
5.20
5.7
5.6
9.5
8.7
48.4
48.5
3 HP
LP
88 2.04 2.70
2.77
4.00
4.10
8.2
1.8
10.4
2.7
52.1
49.4
4 HP
LP
68 1.85 1.77
2.10
3.86
3.56
5.0
4.6
7.7
7.1
72.5
68.8
5 HP
LP
81 2.07 3.22
3.66
5.38
7.31
8.5
5.9
13.5
6.1
26.8
20.1
6 HP
LP
60 1.61 2.58
2.69
5.30
6.56
7.8
5.9
8.9
7.1
85.5
92.5
7 HP
LP
101 2.23 1.30
1.67
3.44
3.67
9.5
5.9
11.1
7.7
46.6
48.4
8 HP
LP
74 1.93 2.32
2.46
4.0
4.5
14.3
12.4
17.6
16.2
91.9
67.9
9 HP
LP
60 1.61 0.72
0.90
3.8
5.2
7.5
7.1
12.3
11.6
21.5
20.2
P values +0.21
<0®5b
+0.62
<005b
—2.74
c0.Olc
—3.78
1.22
c0.01
—4.0
NS
Abbreviations: HP, high protein diet; LP, low protein diet.
a The values reflect the difference between steady-state values of patients on HP and LP diets.
b Statistics are by Student's paired flest (means 5EM) when distributions were normally distributed and by C the Wilcoxon Sign Rank Test
when distributions were non-normal.
body weight varied significantly during either study period,
total albumin turnover was a valid measurement of albumin
synthesis rate.
The rate of albumin synthesis was reduced during the low
protein period (Table 1, Fig. 1A). While the absolute rate of
albumin catabolism only tended to be less during the period of
low protein intake, the fractional rate of albumin catabolism
was less during that period in eight of the nine patients and was
significant for the group as a whole P C 0.005 (Table I). The
decrease in the rate of albumin synthesis was positively cone-
lated with the change in urinary albumin excretion (r 0.869, P
C 0.01). The rate of albumin synthesis as measured by the
pharmacokinetic method was 17.99 1.16 g/1.73 m2/24 hr on
the high protein diet and 15.5 1.52 on the low protein diet.
These values were not significantly different from the results
obtained using the method of Gitlin and Janeway [14], that is,
18.56 1.52 and 14.1 1.89 for the high and low protein diets,
respectively. Similarly, the rates of albumin catabolism were
8.72 1.05 and 8.98 0.98 as measured by the
pharmacokinetic method and 9.29 0.91 and 7.48 1.23 by the
method of Gitlin and Janeway [14] on the high and low protein
diets, respectively, Because the rate of albumin catabolism is
measured more reliably by the latter method, the rates of both
albumin synthesis and catabolism reported in Table 1 are by the
method of Gitlin and Janeway [14].
Creatinine clearance was less during the low protein period in
six patients, but the average difference in creatinine clearance
was quite small —4.00 mI/mm/i .73 m2 and not statistically
significant. Both the renal clearance of albumin and the frac-
tional renal clearance of albumin was less during the low protein
period in every patient but patient 9. In this patient the decrease
in creatinine clearance was of slightly greater magnitude than
the reduction in renal albumin clearance.
Serum albumin concentration was greater during the low
protein period in eight of the nine patients by a mean value of
0.21 0.05, a difference that was significant for the group as a
whole (P C 0.005), Table 1, Fig. lC). This was accompanied by
a significant increase in plasma albumin mass. Other albumin
pools were unaffected by the change in dietary protein intake.
There was no significant change in plasma volume accounting
for the increase in serum albumin concentration.
Discussion
The results of this study indicate that urinary albumin excre-
tion depends on dietary protein intake in patients with
nephrosis of various etiologies. A change in dietary protein
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Table 1. Parameters of albumin homeostasis in nephrotic patients on high and low protein dietsa (Continued)
Renal
albumin
clearance
pi/min
Fractional
excretion
of albumin
%
Albumin
synthesis
g/24 hr/
1.73 m2
Albumin
catabolism
9/24 hr/
1.73 m2
Fractional albumin
catabolic rate:
% of plasma pool
per 24 hr
Plasma
volume
mlf kg
Total
albumin
mass
Extravascular
albumin mass
Plasma
albumin
mass
gIl .73 m2
1916
1106
2.93
1.96
23.7
14.2
6.8
4.7
28.6
20.6
38.3
38.1
47.9
56.5
24.1
33.7
23.8
22.8
201
179
.315
.279
14.8
14.7
9.1
9.0
10.3
8.49
40.0
46.0
214
282
126
176
88
106
249
52
.406
.089
19.8
5.7
11.6
3.9
15.26
4.59
37.6
41.0
148
126
72
41
76
85
210
161
.271
.219
15.6
16.5
10.6
11.9
17.97
19.19
52.1
46.3
128
100
69
38
59
62
220
134
.685
.408
19.3
11.8
10.8
5.9
9.31
4.54
53.2
52.7
201
215
85
85
116
130
195
143
.245
.166
19.3
14.1
11.5
8.2
20.54
13.02
39.1
37.9
100
100
44
37
56
63
499
258
1.07
.533
16.1
11.5
6.6
5.6
13.75
10.98
45.7
38.7
107
81
59
30
48
51
478
319
.520
.576
26.5
26.7
12.2
14.3
26.52
23.07
29.8
37.9
117
173
71
111
46
62
652
506
.303
.251
11.9
10.9
4.4
3.8
20.96
11.88
47.1
54.6
40
68
19
36
21
32
—188
<001c
—0.252
<0.05
—4.54
<0,05b
—1.81
NSb
—5.21
<0005b
+1.14
NSb
+10.96
NSb
+2.07
NSb
+8.89
<0005b
intake leads to a change in urinary albumin excretion within 14
days. The dependency of urinary albumin excretion on dietary
protein intake is not due to changes in serum albumin concen-
tration leading to change in the filtered load of albumin. Urinary
albumin excretion is increased during the period of higher
protein intake, regardless of dietary order, at which time serum
albumin concentration is reduced. It is possible that glomerular
filtration of albumin remained constant while renal tubular
reabsorption and catabolism of albumin is increased on the low
protein diet. However, since the albumin catabolic rate is
reduced during the low protein diet period in nearly all patients
studied, we feel that such a change in renal albumin metabolism
cannot be entirely responsible for the reduced urinary albumin
excretion. In addition, the magnitude of the difference in
albumin catabolic rate between the two dietary periods tends to
be greater in the patients with the greatest change in urinary
albumin excretion. This result is the opposite of what would be
expected if albumin catabolism increased reciprocally with
decreasing albuminuria while glomerular filtration of albumin
remained constant. The change in renal albumin clearance
brought about by changes in dietary protein intake could be
accounted for in part by a change in glomerular filtration rate
(GFR) inasmuch as creatinine clearance approximates GFR.
However, the change in albumin clearance is greater than the
change in creatinine clearance in all but one patient. The change
in albumin excretion then most likely reflects changes in the
ultrafiltration characteristics of the glomerulus, either struc-
tural, hemodynamic, or a combination of both.
Albumin is catabolized by a first order process [15]. The
increase in plasma albumin mass that occurs during the low
protein period should lead to an increased absolute rate of
albumin catabolism. Albumin catabolic rate, however, tended
to be less during consumption of the low protein diet. To assess
the effect of dietary protein intake, independent of plasma
albumin mass, fractional albumin catabolic rate was measured.
Fractional albumin catabolic rate—the percent of the plasma
pool catabolized per day—is independent of plasma albumin
mass and is significantly reduced during the low protein period.
This may be the result of a reduced rate constant for albumin
breakdown or represents reduced renal reabsorption and sub-
sequent catabolism of filtered albumin. The reduced albumin
fractional catabolic rate tends to stabilize the serum albumin
concentration at a higher level during the period of low protein
intake.
Several laboratory studies have shown that albuminuria can
be reduced or prevented entirely in experimental renal diseases
in animals by a reduction in dietary protein intake from the
onset of experimental renal injury either from an injection of
antiserum or reduction in renal mass [8—10]. The results of the
present study indicate that reduction of dietary protein intake
will reduce urinary albumin excretion in humans with estab-
lished nephrotic syndrome because in six of the studies the
change in urinary albumin excretion occurred subsequent to a
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A
Albumin synthetic
rate
E
c)
C)
E
h
C)
28
24
20
16
12 c
N
P < 0.05
High Low
protein
4.0
L
3.0 —
2.0
1.0
/.
0
'-a
/0
C)
/
0
/
P <0.01
High Low
protein
P < 0.005
High Low
protein
B C increased, that is, 18.56 1.52 g/1.73 m2124 hr, but more than
Urinary albumin Serum albumin half of the additional albumin synthesized on the high protein
excretion concentration . . .diet appeared in the urine. This double effect of dietary protein
intake, serving either directly or indirectly to increase albumin
synthesis rate on the one hand and net urinary albumin loss on
the other, may partially explain the failure of some nephrotic
patients to improve serum albumin concentration despite high
protein intake.
Reduction in dietary protein intake might reduce the progres-
sion of some renal disease. Therefore, it is important to know
whether patients with the nephrotic syndrome can tolerate
reduction in dietary protein intake. We have demonstrated that
although reduction in dietary protein intake results in a signif-
icantly reduced rate of albumin synthesis, plasma albumin mass
increases significantly and total body albumin tends to rise in
nephrotic patients consuming a low protein diet. The salutory
effect of the low protein diet on the plasma albumin mass in
nephrotic patients may be due to a reduction in the urinary
albumin loss that occurred on the low protein diet, offsetting the
reduction in albumin synthetic rate.
Since the rate of albumin synthesis as measured by the
pharmacokinetic method measures all albumin turnover by all
routes, a value for that measurement significantly higher than
Fig. 1. A Change in the rate of albumin synthesis that occurs with that measured by the method of Gitlin and Janeway [14] wouldisocaloric reduction in dietary protein intake. B Change in urinary
albumin excretion that occurs with isocaloric reduction in dietary be consistent with a nonrenal loss of albumin, such as would
protein intake. C Change in serum albumin concentration that occurs occur with stool losses. The obvious agreement between albu-
with isocaloric reduction in dietary protein intake. Open circles repre- mm synthesis rate measured with both methods indicates that
sent data from patients 7 through 9. The low protein diet was adminis- the loss of intact (noncatabolized) albumin by nonrenal routestered to those patients in reverse order. Closed circles represent .
patients I through 6 who were administered a high protein diet first. was negligible in these patients.Both patients with amyloidosis failed to alter the rate of
albumin synthesis when dietary protein content was altered.
reduction in dietary protein intake. The decrease in urinary While this response may represent random variation within the
albumin excretion was significant for these six patients, that is, patient population studied, it may instead be disease specific
P < 0.05. and the result of some process such as hepatic involvement with
High protein diets generally have been recommended for amyloid. Urinary albumin excretion and renal albumin clear-
nephrotic patients based on a report of Blainey [31. This was a ance decreased in all patients while they were on the low
study carried out in three patients, each of whom received protein diet, but the magnitude of change was not normally
sequentially increasing dietary protein intake. Serum albumin distributed [19]. It is possible that patients with some forms of
concentration increased in these patients, but all underwent a renal disease may respond to dietary protein restriction with a
vigorous diuresis during the study. Plasma volume contraction much greater reduction in urinary albumin excretion than may
may have contributed substantially to the increase in serum others. Whether the interpatient variability that we observed is
albumin concentration observed by that investigator. During the result of heterogeneity in disease or due to other factors will
the course of that study creatine clearance decreased substan- require further investigation.
tially in the two patients in whom it was measured. The Recent work [8] clearly demonstrates the potential danger of
decrease in creatinine clearance should have resulted in a consumption of a high protein diet in the presence of renal
decrease in urinary protein excretion, however, urinary protein disease. It is indeed possible that nephrotic patients might
excretion increased during the first several weeks of the study eventually suffer depletion of amino acid stores by long-term
and returned to the initial value by the end of the final balance reduction of dietary protein intake. Clearly long-term examina-
period. The increase in serum albumin concentration occurring tion of the effect of restriction in dietary protein intake on
during the period of low protein consumption reported in our nitrogen balance will be of added value.
study was due to an increase in plasma albumin mass rather While it is not clear from these studies whether long-term
than serum protein concentration resulting from plasma volume dietary protein restriction would cause depletion of body pro-
contraction, since plasma volume remained constant. tein stores in nephrosis, albumin pools are not disturbed by
The average rate of albumin synthesis for the nine patients reduction in protein intake for up to 4 weeks even in those
while on the low protein diet was 14.01 1.89 g/l .73 m2, a value patients in whom the reduction in urinary albumin excretion
within the normal rate of albumin synthesis for humans as was only slight.
measured by others [201 and in our own laboratory [131.
Albumin synthesis was not increased despite marked reduction
in both the vascular and extravascular albumin pools. While Portions of this study were supported by a United States Veterans
patients were on the high protein diet, albumin synthesis was Administration Merit Review Grant, United States Public Health Ser-
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